Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles

Apple Inc. (AAPL.US) launches Apple Business platform to expand the growth space of map advertising and service revenue.

US Stock Market Move | Unmanned aerial vehicle (UAV) concept stocks strengthened, Swarmer (SWMR.US) rose over 35%

Adding AI computing power layout Microsoft Corporation (MSFT.US) takes over Oracle Corporation (ORCL.US) and OpenAI abandons the data center project.
Apple Inc. (AAPL.US) launches Apple Business platform to expand the growth space of map advertising and service revenue.

US Stock Market Move | Unmanned aerial vehicle (UAV) concept stocks strengthened, Swarmer (SWMR.US) rose over 35%

Adding AI computing power layout Microsoft Corporation (MSFT.US) takes over Oracle Corporation (ORCL.US) and OpenAI abandons the data center project.

RECOMMEND

Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026

Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026

Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026


